Optimal Donor Selection for Allogeneic Stem Cell Transplantation in the Era of Post-transplant Cyclophosphamide: A Scoping Review
Allogeneic hematopoietic stem cell transplantation (HSCT) remains a primary curative treatment for numerous hematologic disorders. Historically, the success of HSCT relied on HLA matching to mitigate Graft-versus-Host Disease (GVHD); however, since fewer than 30% of patients have a matched family member, the field has...